MedTrace Logo

Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI

NCT03045562 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 536

Last updated 2017-02-07

No results posted yet for this study

Summary

To evaluate the influence of Salvianolate injection on myocardial microcirculation perfusion in subjects with STEMI who underwent primary PCI

Conditions

  • STEMI - ST Elevation Myocardial Infarction

Interventions

DRUG

Normal saline

Patients will be assigned to receive 100ml of normal saline in catherter room setting,and following similar medicine once daily for 7 days.

DRUG

Salvianolate injection

Patients will be assigned to receive Salvianolate injection dissolved in 100ml of normal saline in catherter room setting,and following similar medicine once daily for 7 days.

Sponsors & Collaborators

  • Green Valley Group of China

    lead INDUSTRY

Principal Investigators

  • Junbo Ge, doctor · Shanghai Zhongshan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-20
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03045562 on ClinicalTrials.gov